- Christopher Cates, general practitioner (chriscates@emailmsn.com)
- Manor View Practice, Bushey, Hertfordshire WD2 2NN
Background
Definition Asthma is characterised by dyspnoea, cough, chest tightness, wheezing, variable airflow obstruction, and airway hyper-responsiveness. The diurnal variation of peak expiratory flow rate is increased in people with asthma. Chronic asthma is defined here as asthma requiring maintenance treatment. Asthma is classified differently in the United States and United Kingdom (box): where necessary, the text specifies the system of classification used. 1 2 Acute asthma is defined here as an exacerbation of underlying asthma requiring urgent or emergency treatment, and will be dealt with in a separate “Extract from Clinical Evidence.”3
Interventions
Beneficial:
Inhaled short acting β2 agonists as needed for symptom relief
Low dose, inhaled corticosteroids in mild persistent asthma
Adding inhaled long acting β2 agonists to inhaled corticosteroids in poorly controlled asthma (for symptom control)
Likely to be beneficial:
Leukotriene antagonists for people with mild to moderate persistent asthma
Ineffective or harmful:
Regular use of β2 agonists in mild intermittent asthma
Classification of severity for chronic asthma
United States
Asthma is classified by symptoms of severity. Even people with mild intermittent asthma can develop severe exacerbations if exposed to appropriate stimuli.
Mild intermittent asthma—symptoms less than weekly with normal or near normal lung function
Mild persistent asthma—symptoms more than weekly but less than daily with normal or near normal lung function
Moderate persistent asthma—daily symptoms with mild to moderate variable airflow obstruction
Severe asthma—daily symptoms and frequent night symptoms, and moderate to severe variable airflow obstruction
United Kingdom
Chronic asthma in ambulatory settings is graded according to the amount of medication required to keep symptoms controlled. People are classified stepwise according to the drugs they need for symptom control.
Step 1—occasional β agonists for relief of symptoms
Step 2—in addition, regular, inhaled anti-inflammatory agents (such as inhaled corticosteroids, cromoglycate, or nedocromil)
Step 3—in addition, high dose …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012